Diamond Biotechnology Co., Ltd (TPEX:6815)

Diamond Biotechnology Revenue

Diamond Biotechnology had revenue of 317.60M TWD in the half year ending June 30, 2025, with 7.19% growth. This brings the company's revenue in the last twelve months to 698.11M, down -1.33% year-over-year. In the year 2024, Diamond Biotechnology had annual revenue of 768.25M with 24.70% growth.

• Revenue (ttm): 698.11M
• Revenue Growth: -1.33%
• P/S Ratio: 3.76
• Revenue / Employee: n/a
• Employees: 45
• Market Cap: 2.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	768.25M	152.16M	24.70%
Dec 31, 2023	616.10M	181.25M	41.68%
Dec 31, 2022	434.84M	39.64M	10.03%
Dec 31, 2021	395.20M	88.81M	28.99%
Dec 31, 2020	306.39M	38.04M	14.17%